相关实验视频

Updated: Jun 4, 2025

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

来自Acanthopanax senticosus茎的葡萄糖:结构和抗色直肠癌活性

Qichao Liang¹, Di Han¹, Le Yang²

¹State key laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China.

International journal of biological macromolecules

|December 24, 2024

概括

来自Acanthopanax senticosus的一种新型葡萄糖,ASPN-1,通过增强免疫反应,显示出对结直肠癌的抗瘤潜力. 这种天然化合物可能通过调节关键的免疫信号分子来提供新的治疗策略.

科学领域:

自然产品化学自然产品化学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

阿坎托帕纳克斯 (Acanthopanax senticosus) 是一种药用植物,具有潜在的治疗化合物.
葡萄糖因其多样化的生物活动而闻名,包括免疫调节作用.

研究的目的:

从A. senticosus的茎中分离和描述一种新型的葡萄糖,ASPN-1.
在体内评估ASPN-1的抗瘤潜力和潜在机制.

主要方法:

使用生化技术净化和阐明ASPN-1的结构.
通过电子显微镜评估ASPN-1的表面形态.
使用CT26.WT小鼠瘤模型进行体内抗瘤实验.
对细胞因子 (IL-2,IFN-γ,TNF-α,TGF-β,IL-10) 的产生进行分析,以确定免疫调节作用.

主要成果:

鉴定出ASPN-1是一种33.31kDa的葡萄糖,具有特定的分支结构.
表面分析揭示了一种具有复杂网络架构的无形粉末.
ASPN-1在CT26.WT小鼠瘤上表现出显著的抑制作用.
用ASPN-1治疗通过增加IL-2,IFN-γ和TNF-α来调节免疫功能,同时降低TGF-β和IL-10.

结论:

ASPN-1是一种来自A. senticosus的新型葡萄糖,具有显著的抗瘤特性.
ASPN-1的抗瘤作用是通过其免疫调节作用进行的.
ASPN-1显示出作为结直肠癌的潜在治疗剂的前景.

关键词:

亚坎托帕纳克斯 (Acanthopanax senticosus) 是一个有感觉的动物.它具有抗瘤活性.葡萄糖是一种葡萄糖.结构性表征结构性表征

更多相关视频

Quantification of Colonic Stem Cell Mutations

Quantification of Colonic Stem Cell Mutations

Published on: September 25, 2015

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...